Cytokine adsorbing columns

Contributions to Nephrology

Volumn 166, Issue , 2010, Pages 134-141

  Taniguchi, Takumi ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ADSORPTION; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; ARTICLE; BLOOD; COMPARATIVE STUDY; DETOXIFICATION; EVALUATION; HUMAN; INSTRUMENTATION; ISOLATION AND PURIFICATION; METHODOLOGY; MULTIPLE ORGAN FAILURE; RAT; RENAL REPLACEMENT THERAPY; SEPSIS;

ADSORPTION; ANIMALS; CYTOKINES; HUMANS; MULTIPLE ORGAN FAILURE; RATS; RENAL REPLACEMENT THERAPY; RESPIRATORY DISTRESS SYNDROME, ADULT; SEPSIS; SORPTION DETOXIFICATION;

EID: 84925934836     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000314863     Document Type: Article

References (26)

1. Cohen J: The immunopathogenesis of sepsis. Nature 2000;420:885-891.
2. Kuhns DB, Alvord WG, Gallin JI: Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in human. J Infect Dis 1995;171:145-152.
3. Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hultner L, Heumann D, Mannel D, Bucala R, Glauser MP: Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med 2000;6:164-170.
4. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL: Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996;27:1201-1206.
5. Carlson DL, Willis MS, White DJ, Horton J W, Giroir BP: Tumor necrosis factor-alphainduced caspase activation mediates endotoxin-related cardiac dysfunction. Crit Care Med 2005;33:1021-1028.
6. Natanson C, Eichenholz P W, Danner RL, Eichacker PQ, Hoffman WD, Kuo GC, Banks SM, MacVittie TJ, Parrillo JE: Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 1989;169:823-832.
7. Bellomo R, Tipping P, Boyce N: Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993;21:522-526.
8. Stegmayr BG: Plasmapheresis in severe sepsis or septic shock. Blood Purif 1996;14:94-101.
9. Bengsch S, Boos KS, Nagel D, Seidel D, Inthorn D: Extracorporeal plasma treatment for the removal of endotoxin in patients with sepsis: clinical results of a pilot study. Shock 2005;23:494-500.
10. Reinhart K, Meier-Hellmann A, Beale R, Forst H, Boehm D, Willatts S, Rothe KF, Adolph M, Hoffmann JE, Boehme M, Bredle DL; EASy-Study Group: Open randomized phase II trial of an extracorporeal endotoxin adsorber in suspected Gram-negative sepsis. Crit Care Med 2004;32:1662-1668.
11. Vincent JL, Laterre PF, Cohen J, BurchardiH, Bruining H, Lerma FA, Wittebole X, De Backer D, Brett S, Marzo D, Nakamura H, John S: A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005;23:400-405.
12. Kellum JA, Song M, Venkataraman R: Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-κB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med 2004;32:801-805.
13. Peng ZY, Carter MJ, Kellum JA: Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Crit Care Med 2008;36:1573-1577.
14. Kellum JA, Venkataraman R, Powner D, Elder M, Hergenroeder G, Carter M: Feasibility study of cytokine removal by hemoadsorption in brain-dead humans. Crit Care Med 2008;36:268-272.
15. Kobe Y, Oda S, Matsuda K, Nakamura M, Hirasawa H: Direct hemoperfusion with a cytokine-adsorbing device for the treatment of persistent or severe hypercytokinemia: a pilot study. Blood Rurif 2007;25:446-453.
16. Tsuchida K, Takemoto Y, Nakamura T, Fu O, Okada C, Yamagami S, Kishimoto T: Lixelle adsorbent to remove inflammatory cytokines. Artif Organs 1998;22:1064-1067.
17. Tsuchida K, Yoshimura R, Nakatani T, Takemoto Y: Blood purification for critical illness: cytokines adsorption therapy. Ther Apher 2006;10:25-31.
18. Nakatani T, Tsuchida K, Fu O, Sugimura K, Takemoto Y: Effects of direct hemoperfusion with a beta2-microglobulin adsorption column on hypercytokinemia in rats. Blood Purif 2003;21:145-151.
19. Tsuda K, Taniguchi T: Effects of extracorporeal treatment with Lixelle on the mortality and inflammatory responses to endotoxin-induced shock in rats. Ther Apher 2006;10:49-53.
20. Tsuchida K, Takemoto Y, Sugimura K, Yoshimura R, Nakatani T: Direct hemoperfusion by using Lixelle column for the treatment of systemic inflammatory response syndrome. Int J Mol Med 2002;10:485-488.
21. Taniguchi T, Hirai F, Takemoto Y, Tsuda K, Yamamoto K, Inaba H, Sakurai H, Furuyoshi S, Tani N: A novel adsorbent of circulating bacterial toxins and cytokines; the effect of direct hemoperfusion with CTR column for the treatment of experimental endotoxemia. Crit Care Med 2006;34:800-806.
22. Taniguchi T, Takemoto Y, Tsuda K, Inaba H, Yamamoto K: Effects of posttreatment with direct hemoperfusion using a CTR column on mortality and inflammatory responses to endotoxin-induced shock in rats. Blood Purif 2006;24:460-464.
23. Taniguchi T, Kurita A, Mukawa C, Yamamoto K, Inaba H: Dose-related effects of direct hemoperfusion using a cytokine adsorbent column for the treatment of experimental endotoxemia. Intensive Care Med 2007;33:539-544.
24. Taniguchi T, Kurita A, Yamamoto K, Inaba H: Comparison of a cytokine adsorbing column and an endotoxin absorbing column for the treatment of experimental endotoxemia. Transfus Apher Sci 2009;40:55-59.
25. Saotome T, Endo Y, Sasaki T, Tabata T, Hamamoto T, Fujino K, Eguchi Y, Tani T, Fujiyama Y: A case of severe acute pancreatitis treated with CTR-001 direct hemoperfusion for cytokine apheresis. Ther Apher 2005;9:367-371.
26. Oda S, Hirasawa H, Matsuda K, Nakanishi K, Matsuda K, Nakamura M, Ikeda H, Sakai M: Cytokine adsorptive property of various adsorbents in immunoadsorption columns and a newly developed adsorbent. Blood Purif 2004;22:530-536.